FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

38998811000001108: Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1610701000001114 Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1610721000001119 Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Is a Sodium valproate 300mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Has AMP Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Valproate sodium true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start